KINEX LABS products are sold exclusively for in-vitro research and laboratory use. By entering, you confirm you are 18 or older and a qualified researcher, and you will not use these compounds for human consumption.
IGF-1 LR3 1 mg is a modified Insulin-like Growth Factor-1 analogue under investigation in cell-proliferation, muscle-biology, and IGF-axis research. The LR3 modification extends the working half-life in research models.
Research Profile
Modified IGF-1 analogue (Long R3)
Studied in IGF-axis, cell-proliferation, and tissue-biology research
Long history of academic research in growth and development
QC verified by HPLC and mass spectrometry
Specifications
Compound: IGF-1 LR3
Dosage: 1 mg per vial
Purity: ≥ 98% (HPLC)
Form: Lyophilized powder
Storage: 2–8 °C (lyophilized); –20 °C (reconstituted)
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.
Specifications
Compound
IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1)
Class
IGF-1 analogue (modified, longer half-life)
Dosage
1 mg per vial
Purity
≥ 98% (HPLC)
Form
Lyophilized powder
Appearance
White to off-white cake
Storage
Store lyophilized at 2–8 °C. Reconstituted: –20 °C, use within 30 days.
Reconstitution
Bacteriostatic water (sold separately)
Research Use
Investigational compound for laboratory research only.
